ClearPoint Neuro, Inc. (CLPT) Financial Statements
Industry: Surgical & Medical Instruments & Apparatus
In fiscal 2025, ClearPoint Neuro reported revenue of $37.0M, up 17.8% from $31.4M the year before. Net income was -$25.5M (a -69.1% net margin), or -$0.90 per diluted share. Gross margin was 61.4% and operating margin was -65.4%. Operating activities generated -$23.9M of cash, leaving -$24.4M of free cash flow. At fiscal year end, ClearPoint Neuro held $97.7M in total assets against $69.7M in total liabilities, including $45.9M of cash and equivalents.
Open the full interactive ClearPoint Neuro financials → Quarterly statements, key ratios, valuation history and price charts.
ClearPoint Neuro Key Stats
| Share Price | $9.81 |
|---|---|
| Market Cap | $295.9M |
| Revenue YoY Growth | +17.8% |
| 52-Week Range | $8.66 – $27.32 |
| Shares Outstanding | 30.2 million (basic, 2026 Q2) |
ClearPoint Neuro Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $12.8M | $16.3M | $20.6M | $24.0M | $31.4M | $37.0M |
| Gross Profit | $9.1M | $11.3M | $13.5M | $13.6M | $19.1M | $22.7M |
| Operating Income | -$6.2M | -$13.4M | -$16.3M | -$22.4M | -$19.7M | -$24.2M |
| Pre-Tax Income | -$6.8M | -$14.4M | -$16.4M | -$22.1M | -$18.9M | -$25.5M |
| Income Tax | — | $0 | $0 | $8,000 | $12,000 | $55,000 |
| Net Income | -$6.8M | -$14.4M | -$16.4M | -$22.1M | -$18.9M | -$25.5M |
| Diluted EPS | -$0.43 | -$0.69 | -$0.68 | -$0.90 | -$0.70 | -$0.90 |
ClearPoint Neuro Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $8.9M | $10.4M | $12.1M | $10.9M |
| Net Income | -$5.9M | -$7.8M | -$9.6M | -$11.3M |
| Diluted EPS | -$0.21 | -$0.27 | -$0.32 | -$0.38 |
ClearPoint Neuro Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $20.1M | $54.1M | $27.6M | $23.1M | $20.1M | $45.9M |
| Current Assets | $25.5M | $61.9M | $51.2M | $36.2M | $33.4M | $63.6M |
| Total Assets | $29.5M | $65.6M | $55.5M | $42.7M | $39.2M | $97.7M |
| Current Liabilities | $3.2M | $4.8M | $6.8M | $7.4M | $10.4M | $10.8M |
| Total Long-Term Debt | $21.3M | $9.8M | $9.9M | $9.9M | — | $49.1M |
| Total Liabilities | $27.1M | $16.8M | $18.6M | $21.5M | $13.8M | $69.7M |
| Shareholders' Equity | $2.4M | $48.8M | $36.9M | $21.2M | $25.4M | $28.0M |
ClearPoint Neuro Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | -$7.8M | -$12.7M | -$16.2M | -$13.7M | -$8.9M | -$23.9M |
| Cash From Investing | -$482,000 | -$168,000 | -$10.7M | $8.9M | -$275,000 | $615,000 |
| Cash From Financing | $22.7M | $46.9M | $409,000 | $296,000 | $6.2M | $50.2M |
| Free Cash Flow | -$7.8M | -$12.9M | -$16.5M | -$14.4M | -$9.3M | -$24.4M |
Figures from ClearPoint Neuro's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full ClearPoint Neuro financials page for every line item.
ClearPoint Neuro Company Profile
| Ticker | CLPT |
|---|---|
| Exchange | Nasdaq |
| Industry | Surgical & Medical Instruments & Apparatus |
| Headquarters | Solana Beach, California |
| Incorporated in | Delaware |
| Fiscal Year End | December 31 |
| SEC Filer Category | Non-accelerated filer, smaller reporting company |
| SEC CIK | 0001285550 |
Frequently Asked Questions
What was ClearPoint Neuro's revenue in fiscal 2025?
ClearPoint Neuro (CLPT) reported revenue of $37.0M for fiscal 2025.
What is ClearPoint Neuro's annual revenue history?
ClearPoint Neuro's annual revenue by fiscal year: 2020: $12.8M; 2021: $16.3M; 2022: $20.6M; 2023: $24.0M; 2024: $31.4M; 2025: $37.0M.
What was ClearPoint Neuro's net income in fiscal 2025?
ClearPoint Neuro reported net income of -$25.5M for fiscal 2025.
What was ClearPoint Neuro's earnings per share (EPS) in fiscal 2025?
ClearPoint Neuro's diluted EPS was -$0.90 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did ClearPoint Neuro generate in fiscal 2025?
ClearPoint Neuro generated -$24.4M of free cash flow in fiscal 2025.
What was ClearPoint Neuro's revenue last quarter?
In its most recent reported quarter (2026 Q2), ClearPoint Neuro reported revenue of $10.9M.
How much debt does ClearPoint Neuro have?
ClearPoint Neuro reported $49.1M of long-term debt, including the current portion, at the end of fiscal 2025.
How many shares of ClearPoint Neuro are outstanding?
ClearPoint Neuro reported a weighted average of 30.2 million basic shares outstanding in 2026 Q2.
What is ClearPoint Neuro's market cap?
Based on its latest closing price, ClearPoint Neuro (CLPT) has a market capitalization of about $295.9M.
When does ClearPoint Neuro's fiscal year end?
ClearPoint Neuro's fiscal year end, as registered with the SEC, is December 31.
Where is ClearPoint Neuro headquartered?
ClearPoint Neuro lists its business address in Solana Beach, California in its SEC filings.
ClearPoint Neuro Competitors & Similar Companies
See all 109 Surgical & Medical Instruments & Apparatus companies →